Erika Jones
Principal Financial Officer, Principal Accounting Officer, SVP of Finance & Corporate ControllerMs. Erika Jones is Principal Financial Officer of Black Diamond Therapeutics, Inc. from October 7, 2024 and as Senior Vice President of Finance and Corporate Controller since February 2024 & January 2021 respectively. She is Principal Accounting Officer of Black Diamond Therapeutics, Inc. from November 19, 2021. Ms. Jones served as the Vice President, Finance at Black Diamond since October 2021. Ms. Jones joined the Company in 2019 and served as Senior Director, Finance from October 2019 to January 2021. Prior to joining the Company, she led the SEC reporting and technical accounting functions as the Director of Finance at Axcella Health Inc., a publicly traded biotechnology company, from May 2016 to October 2019. Prior to Axcella, Ms. Jones was a manager at Ernst & Young. Prior to Axcella, Ms. Jones was at Ernst & Young LLP, a multinational accounting firm, from September 2008 to February 2015, most recently as Manager, Advisory Services. Ms. Jones is a Certified Public Accountant in the Commonwealth of Massachusetts. She holds both a Bachelor’s and Master’s Degree in Accounting from Miami University.
Positions
- Company NameBlack Diamond Therapeutics, Inc.Stock CodeBDTXPositionPrincipal Financial Officer, Principal Accounting Officer, SVP of Finance & Corporate ControllerColleagues
- MAMark A. VellecaCEO, President & Chairman
- BHBrent Hatzis-SchochCOO & General Counsel
- SYSergey YurasovChief Medical Officer
- EBElizabeth BuckCo-Founder & Chief Scientific Officer
- ABAli BehbahaniIndependent Director
- GEGarry E. MenzelIndependent Director
- KDKapil DhingraIndependent Director
- SKSamarth KulkarniLead Independent Director
